Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.

Miñones-Moyano E, Porta S, Escaramís G, Rabionet R, Iraola S, Kagerbauer B, Espinosa-Parrilla Y, Ferrer I, Estivill X, Martí E.

Hum Mol Genet. 2011 Aug 1;20(15):3067-78. doi: 10.1093/hmg/ddr210. Epub 2011 May 10.

PMID:
21558425
2.

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.

Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY.

Cancer Res. 2007 Sep 15;67(18):8433-8. Epub 2007 Sep 6.

3.

MicroRNAs in Parkinson's disease.

Mouradian MM.

Neurobiol Dis. 2012 May;46(2):279-84. doi: 10.1016/j.nbd.2011.12.046. Epub 2012 Jan 5. Review.

PMID:
22245218
4.

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T.

Cancer Res. 2008 Jun 1;68(11):4123-32. doi: 10.1158/0008-5472.CAN-08-0325.

5.

Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.

Kabaria S, Choi DC, Chaudhuri AD, Mouradian MM, Junn E.

FEBS Lett. 2015 Jan 30;589(3):319-25. doi: 10.1016/j.febslet.2014.12.014. Epub 2014 Dec 23.

6.

miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.

Pigazzi M, Manara E, Baron E, Basso G.

Cancer Res. 2009 Mar 15;69(6):2471-8. doi: 10.1158/0008-5472.CAN-08-3404. Epub 2009 Mar 3.

7.
8.

Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.

Bossers K, Meerhoff G, Balesar R, van Dongen JW, Kruse CG, Swaab DF, Verhaagen J.

Brain Pathol. 2009 Jan;19(1):91-107. doi: 10.1111/j.1750-3639.2008.00171.x. Epub 2008 May 7.

PMID:
18462474
9.

Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.

Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, Takamaru H, Niinuma T, Maruyama R, Yamamoto H, Tokino T, Imai K, Toyota M, Shinomura Y.

Carcinogenesis. 2010 Dec;31(12):2066-73. doi: 10.1093/carcin/bgq203. Epub 2010 Oct 5.

PMID:
20924086
10.

Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction.

Miñones-Moyano E, Friedländer MR, Pallares J, Kagerbauer B, Porta S, Escaramís G, Ferrer I, Estivill X, Martí E.

RNA Biol. 2013 Jul;10(7):1093-106. doi: 10.4161/rna.24813. Epub 2013 May 1.

11.

Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b.

Villar-Menéndez I, Porta S, Buira SP, Pereira-Veiga T, Díaz-Sánchez S, Albasanz JL, Ferrer I, Martín M, Barrachina M.

Neurobiol Dis. 2014 Sep;69:206-14. doi: 10.1016/j.nbd.2014.05.030. Epub 2014 Jun 2.

PMID:
24892887
12.

microRNA expression profiling of nasopharyngeal carcinoma.

Li T, Chen JX, Fu XP, Yang S, Zhang Z, Chen KhH, Li Y.

Oncol Rep. 2011 May;25(5):1353-63. doi: 10.3892/or.2011.1204. Epub 2011 Mar 3.

PMID:
21373758
13.

DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer.

Wang Z, Chen Z, Gao Y, Li N, Li B, Tan F, Tan X, Lu N, Sun Y, Sun J, Sun N, He J.

Cancer Biol Ther. 2011 Mar 1;11(5):490-6. doi: 10.4161/cbt.11.5.14550.

PMID:
21383543
14.

Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.

Kubo T, Toyooka S, Tsukuda K, Sakaguchi M, Fukazawa T, Soh J, Asano H, Ueno T, Muraoka T, Yamamoto H, Nasu Y, Kishimoto T, Pass HI, Matsui H, Huh NH, Miyoshi S.

Clin Cancer Res. 2011 Aug 1;17(15):4965-74. doi: 10.1158/1078-0432.CCR-10-3040. Epub 2011 Jun 14.

15.

MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells.

Maki Y, Asano H, Toyooka S, Soh J, Kubo T, Katsui K, Ueno T, Shien K, Muraoka T, Tanaka N, Yamamoto H, Tsukuda K, Kishimoto T, Kanazawa S, Miyoshi S.

Anticancer Res. 2012 Nov;32(11):4871-5.

PMID:
23155254
16.

Pulmonary gene and microRNA expression changes in mice exposed to benzo(a)pyrene by oral gavage.

Halappanavar S, Wu D, Williams A, Kuo B, Godschalk RW, Van Schooten FJ, Yauk CL.

Toxicology. 2011 Jul 29;285(3):133-41. doi: 10.1016/j.tox.2011.04.011. Epub 2011 Apr 30.

17.

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.

Alvarez-Erviti L, Seow Y, Schapira AH, Rodriguez-Oroz MC, Obeso JA, Cooper JM.

Cell Death Dis. 2013 Mar 14;4:e545. doi: 10.1038/cddis.2013.73.

18.

Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease.

Merad-Boudia M, Nicole A, Santiard-Baron D, Saillé C, Ceballos-Picot I.

Biochem Pharmacol. 1998 Sep 1;56(5):645-55.

PMID:
9783733
19.

Identification of blood microRNAs associated to Parkinsonĭs disease.

Margis R, Margis R, Rieder CR.

J Biotechnol. 2011 Mar 20;152(3):96-101. doi: 10.1016/j.jbiotec.2011.01.023. Epub 2011 Feb 3.

20.

Supplemental Content

Support Center